No-credit-check payment plans built and marketed for aesthetic practices
The most aesthetics-focused option here, with no-credit-check approvals and optional default protection — but the collect-over-time model, deferred-interest plan, quote-based pricing, and sharply polarized ratings demand eyes-open adoption.
Denefits is a payment-plan platform, not a lender — it states plainly that it is "Not a Financial Institution." It is one of the most aggressively aesthetics-focused options in this category, with a dedicated med-spa page and messaging around injectables, microneedling, and skin rejuvenation. The draw for owners is approval breadth: there is **no credit check and roughly 95% instant approval**, and the provider, not Denefits, sets the terms and rate. Plans can run large, up to about $40,000–$50,000.
The trade-off is the funding model. Unlike a true BNPL lender that pays the practice a lump sum up front, with Denefits the **practice typically collects over time** as the patient pays. Denefits layers a "payment protection" guarantee on top, so on protected plans the practice is still paid if a patient defaults. Its flagship "EZ Payment Plan" is **deferred-interest** — interest-free if paid within about 12 months, otherwise retroactive interest of roughly 19.4%–19.9% — alongside a no-fee plan and an in-house plan option. Merchant pricing is quote-based (subscription plus per-transaction), and connectivity is **API/white-label only**, with no native med-spa practice-management connectors.
Ideal customer
Med spas that want to approve nearly every patient for in-house-style payment plans on high-ticket aesthetic treatments and are comfortable collecting over time in exchange for broad approval and optional payment protection.
Denefits is the most overtly aesthetics-focused option in this roundup, with a dedicated med-spa page and messaging built around injectables, microneedling, and skin rejuvenation. Crucially, it is a payment-plan platform, not a lender — it states outright that it is "Not a Financial Institution." The owner appeal is approval breadth: no credit check, roughly 95% instant approval, the provider sets the terms and rate, and plans can run up to about $40,000–$50,000, comfortably covering high-ticket packages.
The structural catch is how money flows. With a true BNPL lender the practice is paid a lump sum up front; with Denefits the practice generally collects over time as the patient pays. Denefits offsets this with a "payment protection" guarantee so that, on protected plans, the practice is still paid if the patient defaults. Connectivity is API/white-label only, with no native med-spa practice-management connectors.
Choose Denefits if maximizing approvals on high-ticket aesthetic treatments matters more than up-front funding, and you want a tool that already speaks med-spa. Be deliberate about the trade-offs: model the collect-over-time cash flow, decide which plans you will pay to protect, disclose the deferred-interest mechanics to patients plainly, and get the quote-based fees in writing. Teams that need a native PM integration or guaranteed lump-sum payouts should look elsewhere.
By Med Spa Vendor Hub Editorial Team. Last reviewed June 29, 2026. Independent editorial review — how we score.
Merchant pricing is quote-based, combining a subscription with per-transaction fees, so true cost requires a sales conversation. The practice generally collects over time rather than receiving a lump sum up front, though a "payment protection" guarantee covers protected plans if a patient defaults. The flagship EZ Payment Plan is deferred-interest: interest-free if the patient pays within ~12 months, otherwise retroactive interest of roughly 19.4%–19.9%. Plans can cover up to ~$40,000–$50,000.
EZ Payment Plan
0% if paid in ~12 mo, else ~19.4%–19.9% retroactive
Deferred-interest plan; interest-free only if the balance is cleared within the promotional window.
No-fee plan
Interest-free payment plan option with provider-set terms.
In-house plan
Practice-managed plan with provider-set terms and optional payment protection.
Pricing is researched from public sources and verified periodically; confirm current rates with the vendor.
Independent ratings from third-party review platforms, cited with sources. These are not our score.
A vendor-neutral guide to choosing patient financing for a med spa—covering why financing drives conversion, the six provider models, the deferred-interest trap, merchant economics, and how to match a provider to your patients.
Patient financing has no subscription - the practice pays a merchant discount fee (a % of each financed sale) and the patient pays APR or deferred interest. Here's a transparent 2026 breakdown of real merchant fees and patient rates by lender.
Patient FinancingAffirm is a large general-purpose buy-now-pay-later and installment lender that pays merchants up front and assumes default risk, used by some med spas through Zenoti and Stripe-based POS rather than built for aesthetics.
Patient FinancingAfterpay, owned by Block (Square), is a mainstream buy-now-pay-later provider offering interest-free Pay-in-4 on smaller purchases. Some beauty businesses and med spas use it for retail and lower-ticket services, but it is not a healthcare-built financing product for higher-ticket aesthetic procedures.
Patient FinancingAlphaeon Credit is a purpose-built healthcare credit card for aesthetic, cosmetic, dermatology, and plastic surgery practices, offering deep aesthetics fit but carrying a deferred-interest model and strongly negative consumer sentiment.
